Global HLA (Human Leukocyte Antigen) Typing Market Size To Grow USD 2.4 Billion By 2032 | CAGR of 5.5%.
Category: HealthcareGlobal HLA (Human Leukocyte Antigen) Typing Market to Grow USD 2.4 Billion By 2032
According to a research report published by Spherical Insights & Consulting the Global HLA (Human Leukocyte Antigen) Typing Market Size is to grow from USD 1.4 billion in 2022 to USD 2.4 billion by 2032, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
Get more details on this report -
Browse key industry insights spread across 200 pages with 130 Market data tables and figures & charts from the report on, "Global HLA (Human Leukocyte Antigen) Typing Market Size, Share, and COVID-19 Impact Analysis, By Technique (Molecular Assay, Sequenced-based Molecular Assay, & Non-Molecular Assay), By Product (Reagents & Consumables, Software & Services), By Application (Diagnosis & Research), By End User (Commercial Service Providers, Hospitals and Transplant Centers, Research Labs & Academic Institutes), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022– 2032." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/hla-human-leukocyte-antigen-typing-market
HLA testing determines if patients and donors are compatible with cord blood or bone marrow donations. Human leukocyte antigens (HLA) are proteins that are present in humans. The human immune system uses these markers to determine which cells are native to your body and which are foreign.Furthermore, HLA typing can help with ankylosing spondylitis diagnosis, paternity testing, kidney transplantation, and platelet transfusion. As a result, the market will grow faster. It can also detect narcolepsy, rheumatoid arthritis, a stem cell transplant, and Behcet's illness.
HLA-typing methods have evolved from serology-based to genome-based diagnostic techniques with the introduction of PCR-based genome sequencing and its integration with microfluidics, biomedical devices, and robotics. In comparison to serological techniques, continued technological advances in HLA typing have resulted in higher sample throughput, increased device sensitivity, earlier detection of incompatibility, and improved procedural efficacy. These advantages have increased demand for HLA typing systems from key end users such as research facilities, hospitals, transplant centers, and diagnostic laboratories. Furthermore, The high cost of NGS and PCR systems and equipment. The high cost of this equipment and systems will compound affordability issues, impeding industry development. Poor reimbursement restrictions for organ transplants limit market expansion.
Covid 19 Impacts
The COVID-19 outbreak is expected to have a significant impact on human leukocyte antigen (HLA) typing for the transplant industry. Pharmaceutical and biotech businesses are helping governments throughout the world to battle the COVID-19 epidemic, from vaccine development to planning for bottlenecks in the pharmaceutical supply chain. Several vaccine candidates and chemicals are now being explored in the R&D pipeline. Furthermore, Hydroxychloroquine was widely used to combat COVID-19. Because of the high demand for these therapies, makers of COVID-19 management pharmaceuticals have a bright future, since many rich nations are running out.
The molecular assay segment is influencing the market with the largest market share during the forecast period.
The global HLA typing market is classified into three techniques such as molecular assay, sequenced-based molecular assay, and non-molecular assay. Throughout all categories, the molecular assay sector has the biggest revenue share over the predicted period. Molecular methods such as massively parallel sequencing and probe-based hybridization procedures are the most often utilized in HLA typing. Molecular typing may be achieved using several genetic approaches, including PCR followed by massively parallel sequencing. The process employed differs based on the donors and organs to be transplanted.
The reagents and consumables segment is influencing the largest market share over the forecast period.
Based on the product, the global HLA typing market is bifurcated into different categories such as reagents & consumables, software & services. Among these segments, the reagents and consumables segment is dominating the market during the forecast period owing to the HLA reagents, and consumables are also utilized as supplemental items in a variety of diagnostic test kits, including HLA typing, to improve diagnostic accuracy and speed. According to Thermo Fisher Scientific Inc.'s annual report for 2021, the healthcare, clinical, and pharmaceutical industries are the primary users of reagents.
The diagnosis segment is dominating the market with the largest market share during the forecast period.
Based on application, The global HLA typing market is classified into diagnosis and research. Among these segments, the diagnostic segment has the highest revenue share during the predicted period. It may be used to identify illnesses like rheumatoid arthritis, narcolepsy, and Behcet's disease, driving the market for HLA matching. Mylab Discovery Solutions has announced the launching of the DiscoverSeries HLAB-27 detection kit.
North America influenced the market with the largest market share of 46.94% during the forecast period
Get more details on this report -
North America is expected to lead substantial market expansion throughout the projection period because of the existence of well-established academic institutions and research institutes in the region, as well as the developing genetic ailments, which is the key predictor of the region's largest market share. As a result, excellent healthcare and research facilities are available. Furthermore, the government and businesses are working on advancements in organ transplantation.
Asia Pacific is predicted to experience strong revenue market growth throughout the forecast period owing to improved healthcare infrastructure, well-designed reimbursement rules, and improved economic development, the industry has benefited. Along with improved access to skilled persons and transplant hospitals, laboratories outfitted with cutting-edge technology will propel the business ahead.
Major vendors in Global HLA Typing Market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc., F. Hoffman-La Roche Limited, Pacific Biosciencesand, and other key players.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In August 2022, Roche created a new computerized Light cycler device that aids in the diagnosis of cancer in patients.
- In April 2022, Genome Diagnostics (GenDx), a Dutch molecular diagnostics firm, received approval from Canadian regulators to use its NGSgo-MX11-3 human leukocyte antigen genotyping test in vitro.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the Global HLA Typing Market based on the below-mentioned segments:
Global HLA Typing Market, By Technique
- Molecular Assay
- Sequenced-based Molecular Assay
- Non-Molecular Assay
Global HLA Typing Market, By Product
- Reagents & Consumables
- Software & Services
Global HLA Typing Market, By Application
- Diagnosis
- Research
Global HLA Typing Market, By End User
- Commercial Service Providers
- Hospitals and Transplant Centers
- Research Labs & Academic Institutes
HLA Typing Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?